Malaria Medicines, Markets, and Public Policy

Olusoji Adeyi

Chapter 4 in Global Health in Practice:Investing Amidst Pandemics, Denial of Evidence, and Neo-dependency, 2022, pp 71-126 from World Scientific Publishing Co. Pte. Ltd.

Abstract: This chapter is an exploration of the conceptual origin, design, implementation, governance, and lessons learned from the Affordable Medicines Facility for Malaria (AMFm), with emphasis on the political economy of decision making around findings from its independent evaluation. Its first two sections draw upon the literature, especially but not only Frost and Reich’s report on the origins of what became the AMFm. It gives the reader a driver’s seat perspective of the dynamics of a disruptive innovation in global health. The chapter highlights the failures of the legacy architecture of development assistance for health, including how the United States Agency for International Development (USAID) and United States President’s Malaria Initiative (US-PMI, an initiative led by USAID) undermined the health interests of the poor in countries that USAID and US-PMI claimed to serve. It recalls published evidence of the empirical success of the AMFm. It examines the strategic failure of the Global Fund Board, lessons learned, the potential applicability of the private–public approach to other health commodities and countries, and the implications of this experience for evidence-based decisions in global health and development assistance.

Keywords: Africa; AIDS; Apartheid; Bangladesh; Belgium; Biden; CDC; Colonialism; Congo; Corruption; COVID; Development; Development Assistance; Diagnostics; Disease; Ebola; Economics; Efficiency; Epidemiology; Equity; Financing; Foreign Aid; Gavi; Ghana; Global Health; Health; Health Care; Health Economics; Health Financing; Health Services; Health System; HIV; Imperialism; Incentives; Infrastructure; Innovation; Investing; Liverpool; Loan; London; Malaria; Market Failure; Medicine; Mining; Neo-dependency; Nepal; Netherlands; Nigeria; Pandemic; Pharmaceuticals; Industry; NGO; Obama; Oxfam; Policy; Political Economy; Private Sector; Public Health; Public Policy; Public Sector; Public-Private Partnership; Putin; Racism; Russia; Service Delivery; Slavery; Social Engineering; Soviet; Subsidy; SWAp; Technical Assistance; TRIPS; Trump; Tuberculosis; Universal Health Coverage; USAID; USSR; Vaccine; WHO; World Bank; WTO; Zambia (search for similar items in EconPapers)
JEL-codes: H51 I15 I18 (search for similar items in EconPapers)
Date: 2022
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.worldscientific.com/doi/pdf/10.1142/9789811245961_0004 (application/pdf)
https://www.worldscientific.com/doi/abs/10.1142/9789811245961_0004 (text/html)
Ebook Access is available upon purchase.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:wsi:wschap:9789811245961_0004

Ordering information: This item can be ordered from

Access Statistics for this chapter

More chapters in World Scientific Book Chapters from World Scientific Publishing Co. Pte. Ltd.
Bibliographic data for series maintained by Tai Tone Lim ().